Circular RNAs in acute myeloid leukemia

Abstract Although mechanistic studies clarifying the molecular underpinnings of AML have facilitated the development of several novel targeted therapeutics, most AML patients still relapse. Thus, overcoming the inherent and acquired resistance to current therapies remains an unsolved clinical proble...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vijendra Singh, Mohammed Hafiz Uddin, Jeffrey A. Zonder, Asfar S. Azmi, Suresh Kumar Balasubramanian
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/e69252ad152d4db9abeb3705116de2f9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e69252ad152d4db9abeb3705116de2f9
record_format dspace
spelling oai:doaj.org-article:e69252ad152d4db9abeb3705116de2f92021-11-21T12:02:26ZCircular RNAs in acute myeloid leukemia10.1186/s12943-021-01446-z1476-4598https://doaj.org/article/e69252ad152d4db9abeb3705116de2f92021-11-01T00:00:00Zhttps://doi.org/10.1186/s12943-021-01446-zhttps://doaj.org/toc/1476-4598Abstract Although mechanistic studies clarifying the molecular underpinnings of AML have facilitated the development of several novel targeted therapeutics, most AML patients still relapse. Thus, overcoming the inherent and acquired resistance to current therapies remains an unsolved clinical problem. While current diagnostic modalities are primarily defined by gross morphology, cytogenetics, and to an extent, by deep targeted gene sequencing, there is an ongoing demand to identify newer diagnostic, therapeutic and prognostic biomarkers for AML. Recent interest in exploring the role of circular RNA (circRNA) in elucidating AML biology and therapy resistance has been promising. This review discerns the circular RNAs’ evolving role on the same scientific premise and attempts to identify its potential in managing AML.Vijendra SinghMohammed Hafiz UddinJeffrey A. ZonderAsfar S. AzmiSuresh Kumar BalasubramanianBMCarticleAcute myeloid leukemiaNon-coding RNACircular RNANeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENMolecular Cancer, Vol 20, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Acute myeloid leukemia
Non-coding RNA
Circular RNA
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Acute myeloid leukemia
Non-coding RNA
Circular RNA
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Vijendra Singh
Mohammed Hafiz Uddin
Jeffrey A. Zonder
Asfar S. Azmi
Suresh Kumar Balasubramanian
Circular RNAs in acute myeloid leukemia
description Abstract Although mechanistic studies clarifying the molecular underpinnings of AML have facilitated the development of several novel targeted therapeutics, most AML patients still relapse. Thus, overcoming the inherent and acquired resistance to current therapies remains an unsolved clinical problem. While current diagnostic modalities are primarily defined by gross morphology, cytogenetics, and to an extent, by deep targeted gene sequencing, there is an ongoing demand to identify newer diagnostic, therapeutic and prognostic biomarkers for AML. Recent interest in exploring the role of circular RNA (circRNA) in elucidating AML biology and therapy resistance has been promising. This review discerns the circular RNAs’ evolving role on the same scientific premise and attempts to identify its potential in managing AML.
format article
author Vijendra Singh
Mohammed Hafiz Uddin
Jeffrey A. Zonder
Asfar S. Azmi
Suresh Kumar Balasubramanian
author_facet Vijendra Singh
Mohammed Hafiz Uddin
Jeffrey A. Zonder
Asfar S. Azmi
Suresh Kumar Balasubramanian
author_sort Vijendra Singh
title Circular RNAs in acute myeloid leukemia
title_short Circular RNAs in acute myeloid leukemia
title_full Circular RNAs in acute myeloid leukemia
title_fullStr Circular RNAs in acute myeloid leukemia
title_full_unstemmed Circular RNAs in acute myeloid leukemia
title_sort circular rnas in acute myeloid leukemia
publisher BMC
publishDate 2021
url https://doaj.org/article/e69252ad152d4db9abeb3705116de2f9
work_keys_str_mv AT vijendrasingh circularrnasinacutemyeloidleukemia
AT mohammedhafizuddin circularrnasinacutemyeloidleukemia
AT jeffreyazonder circularrnasinacutemyeloidleukemia
AT asfarsazmi circularrnasinacutemyeloidleukemia
AT sureshkumarbalasubramanian circularrnasinacutemyeloidleukemia
_version_ 1718419337245622272